Gynaecological cancer RCR consensus statements

The RCR consensus process was initially developed in 2016 to help reduce variation in UK radiotherapy practice. The gynaecological cancer consensus statements should serve as a practical stimulus for gynaecological cancer teams to review their current radiotherapy service to ensure that they are able to deliver optimal treatment for their patients. They should be adopted in parallel with relevant National Institute for Health and Care Excellence (NICE) guidance.

These areas are covered by the consensus statements: 

1. Image guided and adaptive radiotherapy (IG-ART) for mobile gynaecological targets
2. Brachytherapy
3. Imaging and follow up including late effects
4. Reirradiation of gynaecological cancers
5. Molecular testing and sentinel lymph node assessment in endometrial cancer